In the present study, we aimed to observe the patterns of ERG immunoexpression and PTEN immunohistochemical loss in prostate cancer precursor lesions (HGPIN), invasive prostate carcinoma, as well as in IDCP in correlation with the immunohistochemical expression in the adjacent invasive carcinoma. The gene discussed is ERG; the disease is prostate carcinoma.